| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow—a long-term follow-up
|
Diel, I.J.
|
|
|
19 |
12 |
p. 2007-2011
|
artikel
|
| 2 |
Age of onset in familial cancer
|
Brandt, A.
|
|
|
19 |
12 |
p. 2084-2088
|
artikel
|
| 3 |
author index
|
|
|
|
19 |
12 |
p. 2111-2123
|
artikel
|
| 4 |
Bevacizumab-associated osteonecrosis of the jaw
|
Greuter, S.
|
|
|
19 |
12 |
p. 2091-2092
|
artikel
|
| 5 |
Corrections to “Phase I clinical trial of i.v. ascorbic acid in advanced malignancy” Ann Oncol 2008; 19: 1969-1974, 2008
|
|
|
|
19 |
12 |
p. 2095
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
19 |
12 |
p. ii-iii
|
artikel
|
| 7 |
Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer
|
Milano, G.
|
|
|
19 |
12 |
p. 2033-2038
|
artikel
|
| 8 |
Genetic testing for UGT1A1*28 and *6 in Japanese patients who receive irinotecan chemotherapy
|
Akiyama, Y.
|
|
|
19 |
12 |
p. 2089-2090
|
artikel
|
| 9 |
Heterogeneity in cancer guidelines: should we eradicate or tolerate?
|
Pentheroudakis, G.
|
|
|
19 |
12 |
p. 2067-2078
|
artikel
|
| 10 |
Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab
|
Peintinger, F.
|
|
|
19 |
12 |
p. 2020-2025
|
artikel
|
| 11 |
in this issue
|
|
|
|
19 |
12 |
p. 1983
|
artikel
|
| 12 |
Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive tumors
|
Gajda, M.
|
|
|
19 |
12 |
p. 2090-2091
|
artikel
|
| 13 |
Novel neurosensory testing in cancer patients treated with the epothilone B analog, ixabepilone
|
Goel, S.
|
|
|
19 |
12 |
p. 2048-2052
|
artikel
|
| 14 |
‘Out of blue’ Lhermitte's sign: three cases due to low cumulative doses of oxaliplatin
|
Jurado, J.M.
|
|
|
19 |
12 |
p. 2093-2094
|
artikel
|
| 15 |
Phase II study of erlotinib as a salvage treatment for non-small-cell lung cancer patients after failure of gefitinib treatment
|
Lee, D.H.
|
|
|
19 |
12 |
p. 2039-2042
|
artikel
|
| 16 |
Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma
|
Lee, J.
|
|
|
19 |
12 |
p. 2079-2083
|
artikel
|
| 17 |
Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours
|
Gosens, M.J.E.M.
|
|
|
19 |
12 |
p. 2026-2032
|
artikel
|
| 18 |
Prevalence of undertreatment in cancer pain. A review of published literature
|
Deandrea, S.
|
|
|
19 |
12 |
p. 1985-1991
|
artikel
|
| 19 |
Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management
|
Psyrri, A.
|
|
|
19 |
12 |
p. 1992-1999
|
artikel
|
| 20 |
Prognostic factors in 1038 women with metastatic breast cancer
|
Largillier, R.
|
|
|
19 |
12 |
p. 2012-2019
|
artikel
|
| 21 |
Response to low-dose involved-field radiotherapy in patients with non-Hodgkin's lymphoma
|
Luthy, S.K.
|
|
|
19 |
12 |
p. 2043-2047
|
artikel
|
| 22 |
Setting up home-based palliative care in countries with limited resources: a model from Sarawak, Malaysia
|
Devi, B.C.R.
|
|
|
19 |
12 |
p. 2061-2066
|
artikel
|
| 23 |
subject index
|
|
|
|
19 |
12 |
p. 2097-2110
|
artikel
|
| 24 |
Table of Contents
|
|
|
|
19 |
12 |
p. iv-v
|
artikel
|
| 25 |
Targeting Bcl-2 protein in treatment of melanoma still requires further clarifications
|
Pisano, M.
|
|
|
19 |
12 |
p. 2092-2093
|
artikel
|
| 26 |
The clinical significance of radiologically detected silent pulmonary nodules in early breast cancer
|
Lee, B.
|
|
|
19 |
12 |
p. 2001-2006
|
artikel
|
| 27 |
Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer
|
Wan, C.
|
|
|
19 |
12 |
p. 2053-2060
|
artikel
|
Tijdschrift beschrijving